PennyStockSites.com

Belden Inc., Creative Edge Nutrition, Inc., Sirius XM Holdings Inc. and Rexahn Pharmaceuticals, Inc. Featured from Pennystocksites.com on January 17th, 2014

 
Repost This

Miami, FL -- (SBWIRE) -- 01/17/2014 -- Pennystocksites.com a leading online financial newsletter source, Reports on the following Companies: Belden Inc. (NYSE:BDC), Creative Edge Nutrition, Inc. (OTCMKTS:FITX), Sirius XM Holdings Inc. (NASDAQ:SIRI) and Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN).

Every day we scan the markets for the hottest stocks with the best potential for huge gains. Our vast network is second to none when it comes to delivering fast moving stocks and more importantly getting you out in front of them.

Join Us Here: http://pennystocksites.com/

Belden Inc. (NYSE:BDC), Belden Inc. designs, manufactures, and markets signal transmission solutions for the broadcast, enterprise, and industrial markets. It operates in four segments: Broadcast Solutions, Enterprise Connectivity Solutions, Industrial Connectivity Solutions, and Industrial IT Solutions. The Broadcast Solutions segment provides production, distribution, networking infrastructure, and connectivity systems for television broadcast, cable, satellite, and IPTV industries. The Enterprise Connectivity Solutions segment offers solutions for various applications, including LAN solutions, data center solutions, and security and access control. The Industrial Connectivity Solutions segment provides a product portfolio comprising networking components and machine connectivity products for signal transmission, data communication networks, and power supply of devices designed for various applications in industrial automation and machine building. The Industrial IT Solutions segment offers energy networking, control room and factory floor, and transportation networking solutions. Belden Inc. sells its products through distributors, as well as directly to systems integrators, original equipment manufacturers, end-users, and installers. The company was formerly known as Belden CDT Inc. and changed its name to Belden Inc. in May 2007. Belden Inc. was founded in 1902 and is headquartered in St. Louis, Missouri.

Get a Free Technical Analysis on Belden Inc. (NYSE:BDC): http://pennystocksites.com/market-scan/?symbol=bdc

Creative Edge Nutrition, Inc. (OTCMKTS:FITX), Creative Edge Nutrition, Inc., a nutritional supplement company, develops, markets, and sells nutraceuticals and health supplements. It offers a range of capsules, tablets, and powders, as well as science based products in weight management, specific nutrition challenges, energy, and fitness categories. The company’s products comprise HYPER INFUSION, a pre work-out catalyst; AMINO PLEX, a intra-workout recovery catalyst; CENTRO PLEX, an advanced meal replacement product; ALPHA DRIVE to enhance free testosterone levels; VASOBOLIC, a stimulant free nitric oxide pre-cursor; INOVA, a pre-workout supplement; REDEMPTION; FREE REIGN to increase free testosterone; ROGUE, a muscle builder; THYROZINE, a mood elevating thermogenic; HYPE, a high intensity thermogenic; and REGIME, a physique enhancement product. It also provides natural products, such as Hemp Nutra tea, coffee additives, and slimming tea. The company was formerly known as Laufer Bridge Enterprises Inc. and changed its name to Creative Edge Nutrition, Inc. in April 2012. Creative Edge Nutrition, Inc. is headquartered in Madison Heights, Michigan.

Get a Free Technical Analysis on Creative Edge Nutrition, Inc. (OTCMKTS:FITX): http://pennystocksites.com/market-scan/?symbol=avtc

Sirius XM Holdings Inc. (NASDAQ:SIRI), Sirius XM Holdings Inc. provides satellite radio services in the United States and Canada. The company creates and broadcasts commercial-free music; sports talk and live events; comedy; news; exclusive talk and entertainment; and the comprehensive Latin music, sports, and talk programming in radio. It also provides traffic, weather, data, and information services for subscribers in cars, trucks, RVs, boats, and aircraft through SiriusXM Traffic, SiriusXM Travel Link, NavTraffic, NavWeather, SiriusXM Aviation, SiriusXM Marine, Sirius Marine Weather, XMWX Aviation, and XMWX Marine. In addition, the company offers SiriusXM programming through the SiriusXM Internet Radio App for smartphones and other connected devices, as well as online at siriusxm.com. It provides telematics and connected vehicles services, such as safety, security, and convenience services to various automotive manufacturers. The company’s satellite radios are primarily distributed through automakers and retailers, as well as through its Website. As of November 19, 2013, it had approximately 25.6 million subscribers. The company was formerly known as Sirius XM Radio Inc. and changed its name to Sirius XM Holdings Inc. in November 2013. Sirius XM Holdings Inc. was founded in 1990 and is headquartered in New York, New York.

Get a Free Technical Analysis on Sirius XM Holdings Inc. (NASDAQ:SIRI): http://dailymarketreporter.com/market-scan/?symbol=siri

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs. Its clinical stage oncology candidates comprise Archexin, an inhibitor of the protein kinase Akt-1, which has completed a Phase IIa clinical trial for the treatment of pancreatic cancer, as well as is focusing on initiating Phase IIa clinical trials for chemo-resistant solid tumors and hematological malignancies; RX-3117, which has completed an exploratory Phase I clinical study in humans with therapeutic potential in a range of cancers, including colon, lung, and pancreatic cancer; and RX-5902, a small molecule that inhibits the phosphorylation of p68 RNA helicase and focuses on initiating Phase I clinical trials. The company?s pre-clinical pipeline consist of RX-0201-Nano, a nanoliposomal anticancer Akt inhibitor; RX-0047-Nano, a nanoliposomal anticancer HIF-1 alpha inhibitor; and RX-21101, nano-polymer anticancer. It has various collaborative research and development relationships with universities, research institutions, and other organizations, including Teva Pharmaceutical Industries; Korea Research Institute of Chemical Technology; The University of Maryland Baltimore; Revaax Pharmaceuticals LLC; and Rexgene Biotech Co., Ltd. The company is based in Rockville, Maryland.

Get a Free Technical Analysis on Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN): http://pennystocksites.com/market-scan/?symbol=rnn

Disclosure
We are not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit http://pennystocksites.com/disclaimer/ for complete risks and disclosures.

Contact:
news@pennystocksites.com
http://pennystocksites.com/
http://pennystocksites.com/disclaimer/